Baxter Timothy E 4

What Happened

• Timothy E. Baxter, a director of PAVmed Inc. (PAVM), received an award of 13,930 restricted common shares on 2026-04-02. The Form 4 lists the acquisition as an award/grant (transaction code A) with an acquisition price of $0.00 (reported value $0 on the form). This was a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-02; Form 4 filed 2026-04-03 (appears to be timely).
• Transaction type/code: Award/Grant (A); price reported $0.00; reported value $0.
• Vesting: The restricted shares vest on May 20, 2029 and are subject to forfeiture if the required service period is not completed (per the filing footnote).
• Shares owned after transaction: Not specified on the provided filing excerpt.
• Plan: Granted under the issuer’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan.

Context

• Restricted stock awards are common director compensation and typically vest over time; they do not represent an immediate cash transaction or open-market purchase. Such grants compensate service and align director interests with shareholders but do not necessarily signal a near-term trading intent.